What Patients Know About Irritable Bowel Syndrome (IBS) and What They Would Like to Know. National Survey on Patient Educational Needs in IBS and Development and Validation of the Patient Educational Needs Questionnaire (PEQ)

2007 ◽  
Vol 102 (9) ◽  
pp. 1972-1982 ◽  
Author(s):  
Albena Halpert ◽  
Christine B. Dalton ◽  
Olafur Palsson ◽  
Carolyn Morris ◽  
Yuming Hu ◽  
...  
2006 ◽  
Vol 40 (1) ◽  
pp. 37-43 ◽  
Author(s):  
Albena D Halpert ◽  
Alicia C Thomas ◽  
Yuming Hu ◽  
Carolyn B Morris ◽  
Shrikant I Bangdiwala ◽  
...  

1998 ◽  
Vol 114 ◽  
pp. A816
Author(s):  
M O'Sullivan ◽  
N Mahmud ◽  
D Kelleher ◽  
E Lovett ◽  
CA O'Morain

2017 ◽  
Vol 29 (10) ◽  
pp. e13106 ◽  
Author(s):  
J. E. Kurlander ◽  
W. D. Chey ◽  
C. B. Morris ◽  
Y. J. B. Hu ◽  
R. K. Padival ◽  
...  

2011 ◽  
Vol 9 (12) ◽  
pp. 1065-1071.e2 ◽  
Author(s):  
Spencer D. Dorn ◽  
Carolyn B. Morris ◽  
Susan E. Schneck ◽  
Teresa M. Hopper ◽  
Yuming J.B. Hu ◽  
...  

2017 ◽  
Vol 2017 ◽  
pp. 1-11 ◽  
Author(s):  
Yvonne Tse ◽  
David Armstrong ◽  
Christopher N. Andrews ◽  
Alain Bitton ◽  
Brian Bressler ◽  
...  

Background. Chronic idiopathic constipation (CIC) and constipation-predominant irritable bowel syndrome (IBS-C) are common functional lower gastrointestinal disorders that impair patients’ quality of life. In a national survey, we aimed to evaluate (1) Canadian physician practice patterns in the utilization of therapeutic agents listed in the new ACG and AGA guidelines; (2) physicians satisfaction with these agents for their CIC and IBS-C patients; and (3) the usefulness of these new guidelines in their clinical practice. Methods. A 9-item questionnaire was sent to 350 Canadian specialists to evaluate their clinical practice for the management of CIC and IBS-C. Results. The response rate to the survey was 16% (n=55). Almost all (96%) respondents followed a standard, stepwise approach for management while they believed that only 24% of referring physicians followed the same approach. Respondents found guanylyl cyclase C (GCC) agonist most satisfying when treating their patients. Among the 69% of respondents who were aware of published guidelines, only 50% found them helpful in prioritizing treatment choices and 69% of respondents indicated that a treatment algorithm, applicable to Canadian practice, would be valuable. Conclusion. Based on this needs assessment, a treatment algorithm was developed to provide clinical guidance in the management of IBS-C and CIC in Canada.


Sign in / Sign up

Export Citation Format

Share Document